View in EDS

Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma.

Saved in:
Bibliographic Details
Title: Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma.
Authors: Bellmunt J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. joaquim.bellmunt@gmail.com.; Htal Del Mar Research Institute-IMIM, Barcelona, Spain. joaquim.bellmunt@gmail.com., Lalani AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Juravinski Cancer Centre, McMaster University, Hamilton, Canada., Jacobus S; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Wankowicz SA; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA., Polacek L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Takeda DY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Harshman LC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA., Moreno I; Fundación Jiménez Díaz University Hospital, Madrid, Spain., Lundgren K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bossé D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rosenberg JE; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Source: British journal of cancer [Br J Cancer] 2018 Sep; Vol. 119 (6), pp. 707-712. Date of Electronic Publication: 2018 Sep 17.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30220708
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bellmunt+J%22">Bellmunt J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. joaquim.bellmunt@gmail.com.; Htal Del Mar Research Institute-IMIM, Barcelona, Spain. joaquim.bellmunt@gmail.com.<br /><searchLink fieldCode="AU" term="%22Lalani+AA%22">Lalani AA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Juravinski Cancer Centre, McMaster University, Hamilton, Canada.<br /><searchLink fieldCode="AU" term="%22Jacobus+S%22">Jacobus S</searchLink>; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wankowicz+SA%22">Wankowicz SA</searchLink>; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Polacek+L%22">Polacek L</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Takeda+DY%22">Takeda DY</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Harshman+LC%22">Harshman LC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wagle+N%22">Wagle N</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moreno+I%22">Moreno I</searchLink>; Fundación Jiménez Díaz University Hospital, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lundgren+K%22">Lundgren K</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bossé+D%22">Bossé D</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Van+Allen+EM%22">Van Allen EM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Choueiri+TK%22">Choueiri TK</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rosenberg+JE%22">Rosenberg JE</searchLink>; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2018 Sep; Vol. 119 (6), pp. 707-712. <i>Date of Electronic Publication: </i>2018 Sep 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30220708
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-018-0261-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 707
    Titles:
      – TitleFull: Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bellmunt J
      – PersonEntity:
          Name:
            NameFull: Lalani AA
      – PersonEntity:
          Name:
            NameFull: Jacobus S
      – PersonEntity:
          Name:
            NameFull: Wankowicz SA
      – PersonEntity:
          Name:
            NameFull: Polacek L
      – PersonEntity:
          Name:
            NameFull: Takeda DY
      – PersonEntity:
          Name:
            NameFull: Harshman LC
      – PersonEntity:
          Name:
            NameFull: Wagle N
      – PersonEntity:
          Name:
            NameFull: Moreno I
      – PersonEntity:
          Name:
            NameFull: Lundgren K
      – PersonEntity:
          Name:
            NameFull: Bossé D
      – PersonEntity:
          Name:
            NameFull: Van Allen EM
      – PersonEntity:
          Name:
            NameFull: Choueiri TK
      – PersonEntity:
          Name:
            NameFull: Rosenberg JE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2018 Sep
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Numbering:
            – Type: volume
              Value: 119
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1